Table 1– Estimated proportion of multidrug-resistant tuberculosis (MDR-TB) cases among TB notified cases and absolute number of MDR-TB cases notified, 2011
CountryEstimated proportion of notified TB cases with MDR-TB %#Notified pulmonary MDR-TB cases n#
Newly treatedPreviously treatedNewly treatedPreviously treated
High MDR-TB burden countries in the WHO European Region
 Armenia9.4 (7.1–12)43 (38–49)86 (65–110)170 (140–190)
 Azerbaijan22 (19–26)55 (52–60)930 (790–1100)2500 (2300–2700)
 Belarus32 (30–35)76 (72–79)1200 (1100–1300)810 (780–850)
 Bulgaria2.0 (1.1–3.2)26 (19–33)28 (16–46)91 (66–120)
 Estonia23 (17–29)58 (43–71)56 (43–72)44 (33–54)
 Georgia11 (9.6–12)32 (28–35)340 (300–390)420 (370–460)
 Kazakhstan30 (29–32)51 (50–53)3800 (3600–3900)4500 (4300–4600)
 Kyrgyzstan26 (23–31)52 (45–58)970 (830–1100)550 (490–620)
 Latvia13 (10–16)29 (20–40)89 (70–110)28 (19–39)
 Lithuania11 (9.2–13)49 (44–54)170 (140–200)190 (170–210)
 Moldova19 (17–22)64 (60–67)660 (570–760)940 (890–980)
 Russian Federation20 (18–22)46 (41–52)19000 (17000–21000)25000 (23000–29000)
 Tajikistan13 (9.8–16)54 (48–59)540 (420–670)500 (450–550)
 Ukraine16 (14–18)44 (40–49)4400 (3800–5100)5100 (4600–5600)
 Uzbekistan23 (18–30)62 (53–71)2400 (1800–3000)670 (560–760)
High MDR-TB burden countries in other WHO regions (top 3)
 China5.7 (4.6–7.1)26 (22–30)49000 (39000–61000)12000 (10000–14000)
 India2.1 (1.5–2.7)15 (13–17)21000 (15000–27000)45000 (40000–50000)
 Philippines4.0 (2.9–5.5)21 (14–29)7700 (5500–10000)2900 (2000–4000)
  • #: ranges represent uncertainty intervals. WHO: World Health Organization. Data are taken from [2].